ReNerve (ASX:RNV) signed an exclusive distribution partnership agreement with Imbiomex to progress its nerve repair biomaterial product, NervAlign Nerve Cuff, in
Mexico, according to a Thursday Australian bourse filing.
The two companies have now started the regulatory application process to achieve market approval for the product, following which Imbiomex will market and sell the product in Mexico, the filing added.
The company's shares were down nearly 5% in recent Thursday trade.